Suchergebnisse - "Kanwal Raghav"

PubPharm (8)

1

Overall Survival in Phase 3 Clinical Trials and the Surveillance, Epidemiology, and End Results Database in Patients With Metastatic Colorectal Cancer, 1986-2016 : A Systematic Review

enthalten in: JAMA network open | 2022

von Shen, C. | Tannenbaum, D. | Horn, R. | +13

2

Phase II study of durvalumab (anti-PD-L1) and trametinib (MEKi) in microsatellite stable (MSS) metastatic colorectal cancer (mCRC)

in: Journal for ImmunoTherapy of Cancer | 2022

von Ignacio I Wistuba | Andrew Futreal | Xuemei Wang | +20

3

Underreporting of race/ethnicity in COVID-19 research

in: International Journal of Infectious Diseases | 2021

von Kanwal Raghav | Seerat Anand | Anirudh Gothwal | +4

4

Benchmarking Outcomes after Ablative Radiotherapy for Molecularly Characterized Intrahepatic Cholangiocarcinoma

in: Journal of Personalized Medicine | 2021

von Brian De | Ibrahim Abu-Gheida | Aashini Patel | +20

5

Natural history and prognostic factors for localised small bowel adenocarcinoma

in: ESMO Open | 2020

von Jane Thomas | Andreina Colina | Hyunsoo Hwang | +8

6

Retrospective study of nonmucinous appendiceal adenocarcinomas: role of systemic chemotherapy and cytoreductive surgery

in: BMC Cancer | 2017

von Marc Uemura | Wei Qiao | Keith Fournier | +8

7

Clinical utility of circulating cell-free DNA in advanced colorectal cancer.

in: PLoS ONE | 2017

von Allan A Lima Pereira | Maria Pia Morelli | Michael Overman | +14

8

Cancer of Unknown Primary in Adolescents and Young Adults: Clinicopathological Features, Prognostic Factors and Survival Outcomes.

in: PLoS ONE | 2016

von Kanwal Raghav | Hemendra Mhadgut | Jennifer L McQuade | +6

1
[1]